Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
University R&D gets investor infusion
December 11, 2006
| A version of this story appeared in
Volume 84, Issue 50
Biofusion, a British company dedicated to commercializing academic research, has entered a 10-year deal with Cardiff University under which it gains the right to commercialize Cardiff's research-generated intellectual property. Cardiff is taking an equity stake in Biofusion worth roughly $33 million, and Biofusion will create a dedicated investment fund of $16 million for investing in Cardiff ventures. According to Biofusion, the agreement with Cardiff triples the research spending covered by Biofusion's university agreements and expands its business into non-life-sciences research.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter